Status: Recruiting
Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)
PREVENT is a prospective, multicenter, interventional study evaluating the performance of the OverC multi-cancer detection blood test in asymptomatic individuals with cancer risk.
Participants needed: 12,500
Trial details
Age: 40-75Biological sex: AllType: InterventionalSponsor: Guangzhou Burning Rock Dx Co., Ltd.Updated: Jul 6, 2022Locations: 1
Eligibility criteria
Participants must be able to provide a written informed consent form [+3]
Individuals who have an acute infection or inflammation within 14 days prior to... [+12]